PURPOSE To determine changes in cataract surgical rate (CSR) in Fars Province from 2006 to 2010 and identify the contributions of public and private sectors. METHODS This descriptive report is part of the Iranian Cataract Surgery Survey. To determine the provincial CSR, weights of major (>3000 annual surgeries) and minor (≤3000) centers were calculated based on the number of centers chosen fo...

OBJECTIVES Pharmaceutical policies have become paramount in China and other countries of the Asia-Pacific region because of rapidly rising expenditures on drugs. The problems are especially acute in China because expenditures on drugs are typically so large. This article intends to review effects of the policy of drug expenditure containment with primary reference to China, and it proposes some...

The current view is that the financing of R&D for neglected diseases should be provided by the public sector, while R&D itself is best carried out by the private pharmaceutical sector. In response to this model, most current policy proposals are aimed at mobilising substantial public finances to commercialise the neglected disease market, thereby allowing it to compete in company R&D priorities...

Poor drug access continues to be one of the main global health problems. Global inequalities in access to pharmaceuticals are caused by a number of variables including poverty, high drug prices, poor health infrastructure, and fraud and corruption--the latter being the subject of this article. There is growing recognition among policy makers that corruption in the pharmaceutical system can wast...

Funding combination is the most important issue for the companies while they know the amount of required capital. Companies should be careful regarding the appliance of financial providing methods compatible with the investment strategy of company and profitability. This study seeks to examine the relationship between the capital structure and the profitability of pharmaceutical companies in Ir...

Drawing on international examples of published policy objectives for national pharmaceutical policies, we propose a framework for gauging system performance on the health-related goals of policy in the pharmaceutical sector. We review basic policy structures and performance indicators for the seven participating countries of the Commonwealth Fund”s 2007 International Health Policy Survey. We ex...

This paper reviews current marketing practices in the pharmaceutical sector, and their impact on consumer and doctor behaviour. It identifies negative impacts which include misleading advertising, disease mongering and escalating costs. It argues the need to move from industry self-regulation to an independently monitored code of practice for pharmaceutical marketing.

ONGOING DEBATES IN THE PHARMACEUTICAL SECTOR ABOUT INTELLECTUAL PROPERTY, PRICING AND REIMBURSEMENT, AND PUBLIC RESEARCH INVESTMENTS HAVE A COMMON DENOMINATOR: the pursuit of innovation. However, there is little clarity about what constitutes a true pharmaceutical innovation, and as a result there is confusion about what kind of new products should be pursued, protected and encouraged through h...

Este artículo presenta un análisis sobre la información financiera de las instituciones prestadoras servicios salud (IPS) en Colombia, así como evolución indicadores financieros específicos durante los años 2015-2019, con el objetivo identificar factores críticos desdela perspectiva que permitan evidenciar efecto crisis del sector ha tenido finanzas estas organizaciones. La entidades se obtenid...

Addiction Research Centre1, Clinical Toxicology Department2, Cardiac Anaesthesia Research Centre, Emergency Department3, Mashhad University of Medical Sciences, Mashhad, Faculty of Pharmacy, and Pharmaceutical Sciences Research Centre, Tehran University of Medical Sciences4, Iranian Academy of Medical Sciences5, Tehran, Iran, Environmental Health Services, BC Centre for Disease Control, Vancouv...